Claude Franceschi: Comparing the Efficacy of CHIVA and Conventional Stripping and Ablation Techniques
Claude Franceschi, Angiologist Consultant Teacher at Center Marie‑Thérèse, shared a post on LinkedIn about a recent article by Jinghe Zhu et al, published in Annals of Vascular Surgery:
“Preserving the great saphenous vein (GSV), which is the first-choice conduit for potential future arterial grafting, is possible with CHIVA.
Systematic review and meta-analysis comparing the efficacy of CHIVA and conventional stripping and ablation techniques
Objective: Chronic venous disease (CVD), particularly primary lower extremity varicose veins, is a prevalent global health issue. The CHIVA technique is a hemodynamic-based, vein-preserving strategy proposed as a minimally invasive alternative to traditional treatments such as high ligation and stripping (HLS) or endovenous thermal ablation (e.g., radiofrequency or laser).
The CHIVA technique is designed to treat varicose veins while preserving the great saphenous vein (GSV), which is the first-choice conduit for potential future arterial grafting, especially at the infra-inguinal level. It offers theoretical advantages of reduced trauma, fewer complications, and lower recurrence potential. This systematic review aims to evaluate the efficacy and safety of CHIVA relative to established techniques based on current evidence.”
Title: Systematic Review and Meta-Analysis Comparing the Efficacy of CHIVA and Conventional Stripping and Ablation Techniques
Authors: Jinghe Zhu, Hongjie Cui, Menglong Li, Yingfeng Wu
Read the Full Article on Annals of Vascular Surgery․
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 20, 2026, 12:14Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking
-
Apr 20, 2026, 11:15William Aird: A Physiological Approach to Anemia
-
Apr 20, 2026, 10:59Eric Topol: Is the Interferon Pathway a Key Driver of Inflammaging and Aging
-
Apr 20, 2026, 10:47Emmanuel J Favaloro: Emerging Perspectives on Extracellular Vesicles in Hemophilia
-
Apr 20, 2026, 10:21Pierpaolo Di Micco: Honored to Join the ESVM Congress in Lausanne
-
Apr 20, 2026, 08:17Heghine Khachatryan: Key Takeaways from Day 1 – WFH 2026 World Congress
-
Apr 20, 2026, 08:10Justin Nelson-Deering։ Celebrating World Hemophilia Day in Pediatric Care